Publications

Additional Research on Bedaquiline Salts recently published in Acta Crystallographica

2022-01-17T20:25:52+00:00

Improved Pharma is pleased to announce an additional open-source publication describing the structures of Bedaquiline maleate salts that is now available to download.  Previously, our lab was able to identify promising new benzoate salts of Read more

Additional Research on Bedaquiline Salts recently published in Acta Crystallographica2022-01-17T20:25:52+00:00

Improved Pharma announces recent publication on expediting preclinical formulation development of amorphous lapatinib using mini-tab formulations in pediatrics

2022-01-17T20:26:32+00:00

Dr, Stephen Byrn, CSO of Improved Pharma, was a key contributor to a recent publication describing the usefulness of mini-tablets in monitoring the dose-response of lapatinib solid amorphous dispersions in juvenile pigs.   Juvenile pigs have been well-established Read more

Improved Pharma announces recent publication on expediting preclinical formulation development of amorphous lapatinib using mini-tab formulations in pediatrics2022-01-17T20:26:32+00:00

Improved Pharma announces new publication on amorphous dispersions

2022-01-17T20:27:17+00:00

A recent collaboration with our colleagues further advances the field of X-ray pair distribution function analysis applied to the analysis of amorphous solid dispersions. In this paper, we present the results of different polymer:flubendazole Read more

Improved Pharma announces new publication on amorphous dispersions2022-01-17T20:27:17+00:00

Recent research on bedaquiline selected for the November cover of Acta Crystallographic

2022-01-17T20:39:31+00:00

Improved Pharma is pleased to announce the open-source publication of research into finding new salts of bedaquiline, an important drug for the treatment of tuberculosis. The drug is currently marketed in the US as Read more

Recent research on bedaquiline selected for the November cover of Acta Crystallographic2022-01-17T20:39:31+00:00

Improved Pharma presenting at AAPS 2020 PHARMSCI 360 with Rapid Fire Presentation and Poster

2022-02-10T21:53:17+00:00

WEST LAFAYETTE, IND. (PRWEB) OCTOBER 26, 2020 Interact with us via poster number 924440 and the Advances and Innovation in Formulation Development Rapid Fire session. On Wednesday October 28th, Dr. Pamela Smith, COO of Improved Read more

Improved Pharma presenting at AAPS 2020 PHARMSCI 360 with Rapid Fire Presentation and Poster2022-02-10T21:53:17+00:00

Learn about Improved Pharma’s approach to polymorph and salt screening

2020-07-15T20:52:18+00:00

Polymorph screens and salt screens are important components for drug development. The goal of polymorph screening is to try to find all possible crystal forms by small-scale crystallization and to select a stable form that Read more

Learn about Improved Pharma’s approach to polymorph and salt screening2020-07-15T20:52:18+00:00

Improved Pharma’s highly successful AAPS meeting and presentation

2020-04-30T19:01:31+00:00

Improved Pharma, LLC participated in the AAPS PharmSci 360 meeting in San Antonio, TX from Nov 3-6, 2019. The meeting was highly successful and allowed for several discussions surrounding our problem solving strategy.  Our Read more

Improved Pharma’s highly successful AAPS meeting and presentation2020-04-30T19:01:31+00:00

Improved Pharma at AAPS with Rapid Fire Presentation, Poster, and Booth

2022-01-17T20:33:22+00:00

WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 24, 2019 Improved Pharma LLC will be presenting their latest research in the area of high-level X-ray methods using synchrotron-produced X-rays to study amorphous drug formulations. On Monday, November 4th, Read more

Improved Pharma at AAPS with Rapid Fire Presentation, Poster, and Booth2022-01-17T20:33:22+00:00

Poster to be presented at 2019 AAPS PharmSci 360 conference

2020-04-30T19:03:18+00:00

Title: Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis of Drug/Polymer Dispersions: A Comparison of Subtraction Techniques to Isolate Intra- and Intermolecular Interactions Authors: PA Smitha and SR Byrna, GLB de Araujob, CJ Benmorec Affiliations: Read more

Poster to be presented at 2019 AAPS PharmSci 360 conference2020-04-30T19:03:18+00:00
Go to Top